-
1
-
-
0036551421
-
A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone
-
Khan M.A., St Peter J.V., and Xue J.L. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabetes Care 25 (2002) 708-711
-
(2002)
Diabetes Care
, vol.25
, pp. 708-711
-
-
Khan, M.A.1
St Peter, J.V.2
Xue, J.L.3
-
2
-
-
21544466158
-
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
-
Goldberg R.B., Kendall D.M., Deeg M.A., et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 28 (2005) 1547-1554
-
(2005)
Diabetes Care
, vol.28
, pp. 1547-1554
-
-
Goldberg, R.B.1
Kendall, D.M.2
Deeg, M.A.3
-
3
-
-
34447643245
-
Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study
-
Chappuis B., Braun M., Stettler C., et al. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Diabetes Metab Res Rev 23 (2007) 392-399
-
(2007)
Diabetes Metab Res Rev
, vol.23
, pp. 392-399
-
-
Chappuis, B.1
Braun, M.2
Stettler, C.3
-
4
-
-
35148837113
-
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia
-
Deeg M.A., Buse J.B., Goldberg R.B., et al. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia. Diabetes Care 30 (2007) 2458-2464
-
(2007)
Diabetes Care
, vol.30
, pp. 2458-2464
-
-
Deeg, M.A.1
Buse, J.B.2
Goldberg, R.B.3
-
5
-
-
0024160877
-
Banting lecture 1988. Role of insulin resistance in human disease
-
Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
-
(1988)
Diabetes
, vol.37
, pp. 1595-1607
-
-
Reaven, G.M.1
-
6
-
-
0028947949
-
The fourth musketeer-from Alexandre Dumas to Claude Bernard
-
Reaven G.M. The fourth musketeer-from Alexandre Dumas to Claude Bernard. Diabetologia 38 (1995) 3-13
-
(1995)
Diabetologia
, vol.38
, pp. 3-13
-
-
Reaven, G.M.1
-
7
-
-
0028023850
-
Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test
-
Pei D., Jones C.N., Bhargava R., Chen Y.D., and Reaven G.M. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37 (1994) 843-845
-
(1994)
Diabetologia
, vol.37
, pp. 843-845
-
-
Pei, D.1
Jones, C.N.2
Bhargava, R.3
Chen, Y.D.4
Reaven, G.M.5
-
8
-
-
0014898491
-
Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes
-
Shen S.W., Reaven G.M., and Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49 (1970) 2151-2160
-
(1970)
J Clin Invest
, vol.49
, pp. 2151-2160
-
-
Shen, S.W.1
Reaven, G.M.2
Farquhar, J.W.3
-
9
-
-
0019450068
-
Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp
-
Greenfield M.S., Doberne L., Kraemer F., Tobey T., and Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30 (1981) 387-392
-
(1981)
Diabetes
, vol.30
, pp. 387-392
-
-
Greenfield, M.S.1
Doberne, L.2
Kraemer, F.3
Tobey, T.4
Reaven, G.5
-
10
-
-
0033984997
-
Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers
-
Yeni-Komshian H., Carantoni M., Abbasi F., and Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23 (2000) 171-175
-
(2000)
Diabetes Care
, vol.23
, pp. 171-175
-
-
Yeni-Komshian, H.1
Carantoni, M.2
Abbasi, F.3
Reaven, G.M.4
-
11
-
-
0031726145
-
Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease
-
Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 2773-2776
-
-
Yip, J.1
Facchini, F.S.2
Reaven, G.M.3
-
13
-
-
0034926963
-
Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity
-
McLaughlin T., Abbasi F., Lamendola C., Kim H.S., and Reaven G.M. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. Metabolism 50 (2001) 819-824
-
(2001)
Metabolism
, vol.50
, pp. 819-824
-
-
McLaughlin, T.1
Abbasi, F.2
Lamendola, C.3
Kim, H.S.4
Reaven, G.M.5
-
14
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
15
-
-
0042855872
-
International physical activity questionnaire: 12-country reliability and validity
-
Craig C.L., Marshall A.L., Sjostrom M., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003) 1381-1395
-
(2003)
Med Sci Sports Exerc
, vol.35
, pp. 1381-1395
-
-
Craig, C.L.1
Marshall, A.L.2
Sjostrom, M.3
-
16
-
-
0016292507
-
Reappraisal of the role of insulin in hypertriglyceridemia
-
Olefsky J.M., Farquhar J.W., and Reaven G.M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57 (1974) 551-560
-
(1974)
Am J Med
, vol.57
, pp. 551-560
-
-
Olefsky, J.M.1
Farquhar, J.W.2
Reaven, G.M.3
-
17
-
-
0018880112
-
Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia
-
Greenfield M., Kolterman O., Olefsky J., and Reaven G.M. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 18 (1980) 441-446
-
(1980)
Diabetologia
, vol.18
, pp. 441-446
-
-
Greenfield, M.1
Kolterman, O.2
Olefsky, J.3
Reaven, G.M.4
-
18
-
-
0019739196
-
Diabetic hypertriglyceridemia: evidence for three clinical syndromes
-
Reaven G.M., and Greenfield M.S. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes 30 (1981) 66-75
-
(1981)
Diabetes
, vol.30
, pp. 66-75
-
-
Reaven, G.M.1
Greenfield, M.S.2
-
20
-
-
0013963288
-
Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man
-
Farquhar J.W., Frank A., Gross R.C., and Reaven G.M. Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 45 (1966) 1648-1656
-
(1966)
J Clin Invest
, vol.45
, pp. 1648-1656
-
-
Farquhar, J.W.1
Frank, A.2
Gross, R.C.3
Reaven, G.M.4
-
21
-
-
0033677952
-
Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations
-
McLaughlin T., Abbasi F., Lamendola C., Yeni-Komshian H., and Reaven G. Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations. J Clin Endocrinol Metab 85 (2000) 3085-3088
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 3085-3088
-
-
McLaughlin, T.1
Abbasi, F.2
Lamendola, C.3
Yeni-Komshian, H.4
Reaven, G.5
-
22
-
-
0015953288
-
Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects
-
Olefsky J., Reaven G.M., and Farquhar J.W. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53 (1974) 64-76
-
(1974)
J Clin Invest
, vol.53
, pp. 64-76
-
-
Olefsky, J.1
Reaven, G.M.2
Farquhar, J.W.3
-
23
-
-
0034926959
-
Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women
-
McLaughlin T., Abbasi F., Kim H.S., Lamendola C., Schaaf P., and Reaven G. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50 (2001) 795-800
-
(2001)
Metabolism
, vol.50
, pp. 795-800
-
-
McLaughlin, T.1
Abbasi, F.2
Kim, H.S.3
Lamendola, C.4
Schaaf, P.5
Reaven, G.6
-
24
-
-
20944439286
-
Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
-
Nagashima K., Lopez C., Donovan D., et al. Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest 115 (2005) 1323-1332
-
(2005)
J Clin Invest
, vol.115
, pp. 1323-1332
-
-
Nagashima, K.1
Lopez, C.2
Donovan, D.3
-
25
-
-
43249083632
-
Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production
-
Duez H., Lamarche B., Uffelman K.D., et al. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production. J Clin Endocrinol Metab 93 (2008) 1722-1729
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 1722-1729
-
-
Duez, H.1
Lamarche, B.2
Uffelman, K.D.3
-
26
-
-
33244496643
-
The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients
-
Al Majali K., Cooper M.B., Staels B., Luc G., Taskinen M.R., and Betteridge D.J. The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients. Diabetologia 49 (2006) 527-537
-
(2006)
Diabetologia
, vol.49
, pp. 527-537
-
-
Al Majali, K.1
Cooper, M.B.2
Staels, B.3
Luc, G.4
Taskinen, M.R.5
Betteridge, D.J.6
-
27
-
-
0042669791
-
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)
-
Robins S.J., Rubins H.B., Faas F.H., et al. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 26 (2003) 1513-1517
-
(2003)
Diabetes Care
, vol.26
, pp. 1513-1517
-
-
Robins, S.J.1
Rubins, H.B.2
Faas, F.H.3
-
28
-
-
0018649439
-
Atherogenesis: a postprandial phenomenon
-
Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 60 (1979) 473-485
-
(1979)
Circulation
, vol.60
, pp. 473-485
-
-
Zilversmit, D.B.1
-
29
-
-
34447511196
-
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
-
Nordestgaard B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama 298 (2007) 299-308
-
(2007)
Jama
, vol.298
, pp. 299-308
-
-
Nordestgaard, B.G.1
Benn, M.2
Schnohr, P.3
Tybjaerg-Hansen, A.4
-
30
-
-
34447520136
-
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
-
Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Jama 298 (2007) 309-316
-
(2007)
Jama
, vol.298
, pp. 309-316
-
-
Bansal, S.1
Buring, J.E.2
Rifai, N.3
Mora, S.4
Sacks, F.M.5
Ridker, P.M.6
-
31
-
-
26244453309
-
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
-
Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
-
(2005)
Lancet
, vol.366
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
-
32
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2457-2471
-
(2007)
N Engl J Med
, vol.356
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
|